Key result
Age-standardized cardiovascular mortality in Brazil fell ~55% from 1990 to 2023 despite rising prevalence.
Why the study?
Standardized methodology and contemporary epidemiological data are needed to facilitate evidence-based decision-making and strengthen cardiovascular surveillance, research, and policy development in Brazil.
Observational (n=16,351,655)
Yes
This comprehensive national statistical report demonstrates that while age-standardized cardiovascular mortality rates in Brazil have halved since 1990, the absolute burden of cardiovascular diseases and cardiometabolic risk factors continues to rise due to population aging and growth, accompanied by persistent regional disparities and care gaps.
Figure 2 -Standardized methodology for economic estimates in cardiovascular studies.facilitating evidence-based decision-making and strengthening cardiovascular surveillance, research, and policy development in Brazil. HIGHLIGHTS Chapter 1 -Total Cardiovascular Diseases• Cardiovascular diseases remained the leading cause of death in Brazil in 2023.According to GBD 2023 estimates, from 1990 to 2023, the age-standardized CVD mortality rate declined by 54.8%, from 325.2 to 147.0 deaths per 100,000 population, although substantial regional inequalities persisted.• GBD 2023 estimates indicate that 16,351,655 people were living with CVD in Brazil in 2023, a 50% increase since 1990, reflecting mainly population aging and growth.• Over the same period, the age-standardized CVD DALY rate declined by approximately 52%, as estimated by GBD 2023; however, CVD remained a major cause of health loss in Brazil, imposing a substantial burden on the health system.Chapter 2 -Stroke (Cerebrovascular Diseases)• An estimated 2,694,436 people were living with stroke in Brazil in 2023, according to GBD 2023.Despite this large absolute burden, the age-standardized prevalence rate declined by 25.6% from 1990 to 2023.• Over the same period, GBD 2023 estimates show that the age-standardized stroke mortality rate declined by 63.2%, reaching 49.4 deaths per 100,000 population in 2023; mortality remained higher among men and in the North region.• Major gaps in post-stroke care persist: among 21,785 stroke survivors, only 33.1% received physical rehabilitation during hospitalization and 52.7% after discharge, with a mean distance of 79.1 km to rehabilitation centers. Chapter 3 -Acute and Chronic Coronary Heart Disease• According to GBD 2023 estimates, 3,781,434 people were living with ischemic heart disease in Brazil in 2023.Despite the increase in absolute numbers since 1990, the age-standardized prevalence rate declined by 53%, reaching 1,428 per 100,000 population.• Ischemic heart disease remained the leading cause of death in Brazil in 2023, accounting for 158,100 deaths, 10.8% of all deaths and 41.6% of cardiovascular deaths, according to GBD 2023 estimates.The age-standardized mortality rate declined by 54% from 1990 to 2023, reaching 61 per 100,000 population.• Use of coronary revascularization has increased in the Brazilian public health system.Primary PCI procedures more than doubled from 11,099 in 2019 to 24,695 in 2024, while CABG volumes recovered after the COVID-19 pandemic to approximately 21,000 procedures annually in 2023-2024.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) conducted an observational in Cardiovascular Diseases and Risk Factors (n=16,351,655). Cardiovascular diseases and associated metabolic, behavioral, and dietary risk factors vs. Historical baseline (1990) and regional sociodemographic strata was evaluated on Age-standardized cardiovascular disease mortality rate per 100,000 population (95% CI 132.2-155.1). Cardiovascular disease age-standardized mortality in Brazil declined by 54.8% from 325.2 to 147.0 per 100,000 between 1990 and 2023, though prevalent cases rose 50% to 16.35 million.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: